Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04531 |
| Species: | Homo sapiens |
| Position : | chr14:22556439-22556536 |
| Year: | 2025 |
| Title: | A pooled CRISPR screen identifies the T汐2 enhancer element as a driver of TRA expression in a subset of mature human T lymphocytes. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 40160815 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Primary human peripheral blood CD3+ T cells |
| Cell Type: | T cell |
| Cell Ontology ID: | CL:0000084 |
| Experiment Type: | Functional enhancer perturbation assay; Endogenous cis-regulatory element validation |
| Low Throughput Method: | Targeted CRISPR/Cas9 editing of T汐2; Paired-sgRNA T汐2 deletion; Flow cytometry; RT-qPCR; PCR; Sanger sequencing; ICE analysis |
| Target gene : | TRAC |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04549 | chr14:22556439-22556536 | blood | T cell | NA |